WHEELING - Wheeling Hospital recently became the third U.S. hospital in the past week to implant the world's smallest and thinnest cardioverter defibrillator to treat heart failure and sudden cardiac arrest.
Dr. Maninder Bedi, a cardiac electrophysiologist, implanted INCEPTA, a Boston Scientific device, into two men, both age 60. The men are being treated for the protection against life-threatening ventricular arrhythmias.
"Boston Scientific has given physicians the opportunity to better treat our patients while fulfilling the requests of what patients say they want smaller, thinner and long-lasting devices that perform when needed," said Bedi. "In addition, the new device is easier and quicker to implant, enhancing patient comfort."
In late November, the U.S. Food and Drug Administration approved three new Boston Scientific resynchronization therapy defibrillators and implantable cardioverter defibrillators, including INCEPTA.
In addition to its exclusive smaller size, the other advantage of INCEPTA is its 10-year warranty, nearly double that of its competitors.
The first two hospitals to implant the device did so last week: The University of Washington Medical Center, followed by the University of Vanderbilt Medical Center.
"We're proud to be one of the leaders to offer this advanced technology. It's the latest example of our ongoing mission to provide the best medical care possible for our patients," said Ron Violi, Wheeling Hospital chief executive officer.
Bedi said some patients have Web-based monitors placed in their homes that communicate with the device. "Through this technology, physicians can remotely monitor a patient's vital signs and device function," he said. "This helps us better manage their very complex disease. In a survival study, patients with remote monitoring had a lower mortality rate."
A variety of Wheeling Hospital's cardiac services are nationally recognized by independent organizations.
Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties.